Measurement of voriconazole in serum and plasma

Clinical Biochemistry

Volumn 40, Issue 18, 2007, Pages 1378-1385

  Langman, Loralie J ^a   Boakye Agyeman, Felix ^a  

^a MAYO CLINIC   (United States)

Author keywords

Analysis; Therapeutic drug monitoring; Voriconazole

Indexed keywords

VORICONAZOLE;

ARTICLE; CALIBRATOR; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; ROOM TEMPERATURE;

ANTICOAGULANTS; ANTIFUNGAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG MONITORING; DRUG STABILITY; HUMANS; MODELS, BIOLOGICAL; PYRIMIDINES; SERUM; TRIAZOLES;

EID: 36348932293     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.07.024     Document Type: Article

References (30)

1. Perea S., Pennick G.J., Modak A., Fothergill A.W., Sutton D.A., Sheehan D.J., et al. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma. Antimicrob. Agents Chemother. 44 (2000) 1209-1213
2. VFEND® (voriconazole) package insert. Vol. New York, NY: Pfeizer Inc., 2006.
3. Sabo J.A., and Abdel-Rahman S.M. Voriconazole: a new triazole antifungal. Ann. Pharmacother. 34 (2000) 1032-1043
4. Ghannoum M.A., and Kuhn D.M. Voriconazole-better chances for patients with invasive mycoses. Eur. J. Med. Res. 7 (2002) 242-256
5. Murphy M., Bernard E.M., Ishimaru T., and Armstrong D. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 41 (1997) 696-698
6. Martin M.V., Yates J., and Hitchcock C.A. Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs. Antimicrob. Agents Chemother. 41 (1997) 13-16
7. Wildfeuer A., Seidl H.P., Paule I., and Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 41 (1998) 309-319
8. Como J.A., and Dismukes W.E. Oral azole drugs as systemic antifungal therapy. N. Engl. J. Med. 330 (1994) 263-272
9. Borgers M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev. Infect. Dis. 2 (1980) 520-534
10. Potoski B.A., and Brown J. The safety of voriconazole. Clin. Infect. Dis. 35 (2002) 1273-1275
11. Physician's Desk Reference. 59th ed. Montvale, NJ: P.D.R. Thomson, 2005.
12. Ally R., Schurmann D., Kreisel W., Carosi G., Aguirrebengoa K., Dupont B., et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin. Infect. Dis. 33 (2001) 1447-1454
13. Boyd A.E., Modi S., Howard S.J., Moore C.B., Keevil B.G., and Denning D.W. Adverse reactions to voriconazole. Clin. Infect. Dis. 39 (2004) 1241-1244
14. Denning D.W., Ribaud P., Milpied N., Caillot D., Herbrecht R., Thiel E., et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34 (2002) 563-571
15. Pfizer. Product Monograph, VFEND. Compendium of Pharmaceuticals and Specialties, Vol. 40 ed. Ottawa, ON, Canada: Canadian Pharmacists Association, 2005.
16. Lazarus H.M., Blumer J.L., Yanovich S., Schlamm H., and Romero A. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. J. Clin. Pharmacol. 42 (2002) 395-402
17. Teitz Textbook of Clinical Chemistry. 4th ed: WB Saunders Company, 2006: 2448 pp.
18. Ullmann A.J. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr. Med. Res. Opin. 19 (2003) 263-271
19. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 10th ed: McGraw-Hill, 2001.
20. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39 (2001) 954-958
21. Jeu L., Piacenti F.J., Lyakhovetskiy A.G., and Fung H.B. Voriconazole. Clin. Ther. 25 (2003) 1321-1381
22. Law D., Moore C.B., and Denning D.W. Discrepancies associated with the measurement of itraconazole serum concentrations by bioassays. J. Antimicrob. Chemother. 44 (1999) 577-578
23. Stopher D.A., and Gage R. Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column. J. Chromatogr., B, Biomed. Sci. Appl. 691 (1997) 441-448
24. Zhou L., Glickman R.D., Chen N., Sponsel W.E., Graybill J.R., and Lam K.W. Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. J. Chromatogr., B. Anal Technol. Biomed. Life Sci. 776 (2002) 213-220
25. Gage R., and Stopher D.A. A rapid HPLC assay for voriconazole in human plasma. J. Pharm. Biomed. Anal. 17 (1998) 1449-1453
26. Pehourcq F., Jarry C., and Bannwarth B. Direct injection HPLC micro method for the determination of voriconazole in plasma using an internal surface reversed-phase column. Biomed. Chromatogr. 18 (2004) 719-722
27. Pennick G.J., Clark M., Sutton D.A., and Rinaldi M.G. Development and validation of a high-performance liquid chromatography assay for voriconazole. Antimicrob. Agents Chemother. 47 (2003) 2348-2350
28. Khoschsorur G., Fruehwirth F., and Zelzer S. Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum. Antimicrob. Agents Chemother. 49 (2005) 3569-3571
29. Keevil B.G., Newman S., Lockhart S., Howard S.J., Moore C.B., and Denning D.W. Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry. Ther. Drug Monit. 26 (2004) 650-657
30. Vogeser M., Schiel X., and Spohrer U. Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry. Clin. Chem. Lab. Med. 43 (2005) 730-734